Aggregation and fusion of low-density lipoproteins in vivo and in vitro
- 26 July 2013
- journal article
- review article
- Published by Walter de Gruyter GmbH in BioMolecular Concepts
- Vol. 4 (5), 501-518
- https://doi.org/10.1515/bmc-2013-0016
Abstract
Low-density lipoproteins (LDLs, also known as ‘bad cholesterol’) are the major carriers of circulating cholesterol and the main causative risk factor of atherosclerosis. Plasma LDLs are 20- to 25-nm nanoparticles containing a core of cholesterol esters surrounded by a phospholipid monolayer and a single copy of apolipoprotein B (550 kDa). An early sign of atherosclerosis is the accumulation of LDL-derived lipid droplets in the arterial wall. According to the widely accepted ‘response-to-retention hypothesis’, LDL binding to the extracellular matrix proteoglycans in the arterial intima induces hydrolytic and oxidative modifications that promote LDL aggregation and fusion. This enhances LDL uptake by the arterial macrophages and triggers a cascade of pathogenic responses that culminate in the development of atherosclerotic lesions. Hence, LDL aggregation, fusion, and lipid droplet formation are important early steps in atherogenesis.In vitro, a variety of enzymatic and nonenzymatic modifications of LDL can induce these reactions and thereby provide useful models for their detailed analysis. Here, we summarize current knowledge of thein vivoandin vitromodifications of LDLs leading to their aggregation, fusion, and lipid droplet formation; outline the techniques used to study these reactions; and propose a molecular mechanism that underlies these pro-atherogenic processes. Such knowledge is essential in identifying endogenous and exogenous factors that can promote or prevent LDL aggregation and fusionin vivoand to help establish new potential therapeutic targets to decelerate or even block these pathogenic reactions.Keywords
This publication has 117 references indexed in Scilit:
- Effects of phospholipase A2 and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid dropletsJournal of Lipid Research, 2011
- Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopyJournal of Lipid Research, 2011
- The LDL modification hypothesis of atherogenesis: an updateJournal of Lipid Research, 2009
- Thermal Transitions in Human Very-Low-Density Lipoprotein: Fusion, Rupture, and Dissociation of HDL-like ParticlesBiochemistry, 2007
- Zn2+-stimulated Sphingomyelinase Is Secreted by Many Cell Types and Is a Product of the Acid Sphingomyelinase GenePublished by Elsevier BV ,1996
- Lesioned Low-Density Lipoprotein in Atherosclerotic Apolipoprotein E-Deficient Transgenic Mice and in Humans Is Oxidized and AggregatedBiochemical and Biophysical Research Communications, 1995
- In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: Antioxidant effect of albuminBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteinsBiochemical and Biophysical Research Communications, 1989
- Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patientsBiochemical and Biophysical Research Communications, 1989
- Beyond CholesterolThe New England Journal of Medicine, 1989